 |
Articles: Clinical Pharmacology |
Prior Articles
Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema: The Pan-American Collaborative Retina Study Group Results
Ophthalmology, 07/21/09
A Prospective Randomized Evaluation of Topical Gatifloxacin on Conjunctival Flora in Patients Undergoing Intravitreal Injections
Ophthalmology, 07/21/09 Cost-Effectiveness Analysis of Intracameral Cefuroxime Use for Prophylaxis of Endophthalmitis after Cataract Surgery
Ophthalmology, 07/21/09 Intravitreal Ranibizumab May Induce Retinal Arteriolar Vasoconstriction in Patients with Neovascular Age-related Macular Degeneration
Ophthalmology, 07/21/09 Intravitreal Bevacizumab vs Sub-Tenon Triamcinolone Acetonide for Choroidal Neovascularization Attributable to Pathologic Myopia
American Journal of Ophthalmology, 07/21/09 Intravitreal Bevacizumab Therapy for Neovascular Age Related Macular Degeneration Associated with Poor Initial Visual Acuity
British Journal of Ophthalmology, 07/20/09 A randomised trial of bevacizumab and reduced light dose photodynamic therapy in age-related macular degeneration
British Journal of Ophthalmology, 07/20/09 Azathioprine for Ocular Inflammatory Diseases
American Journal of Ophthalmology, 07/17/09 Safety of continuing warfarin therapy during cataract surgery: A systematic review and meta-analysis
Thrombosis Research, 07/17/09 Brimonidine Tartrate 0.15%, Dorzolamide Hydrochloride 2%, and Brinzolamide 1% Compared as Adjunctive Therapy to Prostaglandin Analogs
Ophthalmology, 07/16/09 Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells
Graefe's Archive for Clinical and Experimental Ophthalmology, 07/16/09
Exclusive Author Commentary Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study
British Journal of Ophthalmology, 07/15/09 The Effect of Intravitreal Ranibizumab on the Fellow Untreated Eye with Subfoveal Scarring due to Exudative Age-Related Macular Degeneration
Ophthalmologica, 07/15/09 Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study
Expert Opinion in Pharmacotherapy, 07/15/09 Phosphodiesterase inhibitors and the eye
Clinical and Experimental Ophthalmology, 07/14/09 Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema: The Pan-American Collaborative Retina Study Group at 24 Months
Ophthalmology, 07/14/09 Intravitreal bevacizumab (Avastin) as a treatment of the neovascular complications of laser-induced chorioretinal anastomosis for nonischaemic central retinal vein occlusion
Clinical and Experimental Ophthalmology, 07/14/09 Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
Clinical and Experimental Ophthalmology, 07/14/09 Long-term Results of Intravitreal Bevacizumab Injection for Choroidal Neovascularization Secondary to Angioid Streaks
American Journal of Ophthalmology, 07/13/09 Effect of intracameral triamcinolone acetonide on postoperative intraocular pressure after cataract surgery
Eye, 07/13/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: American Journal of Ophthalmology, Retina, Eye, Cornea
more...
|
250 Available Pages
|
|
